New Zealand Use Of Meningococcal B Vaccine Signals Universal Treatment
This article was originally published in PharmAsia News
Executive Summary
New Zealand’s use of a 1990s vaccine in a campaign to prevent meningococcal B is now the focus of international research, including a new study published by the journal Lancet.